Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ORTHOREBIRTH
Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
ORTHOREBIRTH markets ReBOSSIS, a cotton-like, bioabsorbable synthetic bone-void-filling material that is cleared and sold in the United States, Taiwan, and Japan for use in orthopedic, trauma, spinal, oral, and plastic surgery procedures, and is expanding its microfiber scaffold platform into antibacterial, BMP-combination, and drug-delivery applications.[2][5][6]
- Therapeutic areas
- OncologyRare DiseasesRheumatologyOther
- Modalities
- DeviceHydrogel-based drug delivery therapyNanofiber scaffoldDrug delivery system
- Industry
- Therapeutic Medical Devices
02
Partnerships
Theradaptive (joint development and commercialization of THX-14, combining Theradaptive’s biologic with ORTHOREBIRTH’s 510(k)-approved void-filling material for bone trauma, congenital skeletal defects, and potentially spinal fusion)[1]TEIJIN MEDICAL TECHNOLOGY (entrusted distribution and sales of ReBOSSIS-MT in maxillofacial and plastic surgery in Japan)[3]Meiji University (joint R&D on antibacterial cottony-type artificial bone)[2]Nagoya Institute of Technology (joint R&D on antibacterial cottony-type artificial bone)[2]Keio University (joint R&D on antibacterial cottony-type artificial bone)[2]National Institute of Technology, Okinawa College (joint R&D on cottony drug-delivery carrier with anticancer agents)[2]University of the Ryukyus (joint R&D on adipose stem cell culturing base material)[2]
Beyond the preview
Go deeper on ORTHOREBIRTH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ORTHOREBIRTH.